Natural Biocon Defers Q2 Results, Appoints MD, and Schedules AGM
Natural Biocon (India) Ltd 路 Outcome 路 14 Nov 2026, 11:57 pm
Natural Biocon Defers Q2 Results, Appoints MD, and Schedules AGM Natural Biocon (India) Limited deferred the approval of its unaudited standalone financial results for the quarter ended 30th Sep'26 due to pending audit matters. The Board approved the appointment of Archana Chaitanya Pandya as Managing Director for a five-year term effective 14th Nov'26 to 13th Nov'31, and Kalpana Srinivasan as Secretarial Auditor for FY26鈥揊Y30, both subject to shareholder approval. Following a RoC extension, the 34th AGM is scheduled for 14th Dec'26, with share transfer books closed from 8th Dec'26 to 14th Dec'26.
Original exchange filing (PDF)
More announcements from Natural Biocon (India) Ltd
- Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve The unaudited financial .... 路 14 Nov 2026
- Intimation of approval of extension of time for holding annual general meeting of the company for the financial year ended 31st March 2026 路 03 Nov 2026
- Resignation of Company Secretary and the Managing Director 路 02 Oct 2026
- Intimation for resignation of Managing Director 路 27 Sept 2026
- Intimation for resignation of CS 路 27 Sept 2026
- As per Attachment 路 09 Sept 2026
- AGM 路 05 Sept 2026
- Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 ,inter alia, to consider and approve AGM 路 02 Sept 2026
